Showing results (51-60 of 171) with videos related to
Sort By:
Pageof 18
Expert Review of Anticancer Therapy|August 11, 2018
Current and future therapies for targeting HER2 mutations in gastrointestinal cancerImane El Dika, David H IlsonGastroenterology|October 18, 2017
Management of Patients With Adenocarcinoma or Squamous Cancer of the EsophagusDavid H Ilson, Richard van HillegersbergDiagnostics (Basel, Switzerland)|June 10, 2023
Clinical Utility ofDarren Cowzer, Fergus Keane, Geoffrey Y KuJournal of Gastrointestinal Oncology|January 13, 2017
Phase II study of bevacizumab and preoperative chemoradiation for esophageal adenocarcinomaGeoffrey Y Ku, Manjit S Bains, Do Joong Park, et al.Cancer Chemotherapy and Pharmacology|January 23, 2022
Phase I/Ib study of crenolanib with ramucirumab and paclitaxel as second-line therapy for advanced esophagogastric adenocarcinomaRyan H Moy, Megan Greally, Joanne F Chou, et al.Oncology (Williston Park, N.Y.)|July 12, 2002
Irinotecan, cisplatin, and radiation in esophageal cancerDavid H Ilson, Bruce Minsky, David KelsenCancer|April 12, 2019
Optimal management of gastroesophageal junction cancerMegan Greally, Rajiv Agarwal, David H IlsonAnnals of Surgical Oncology|February 10, 2021
Outcomes of Neoadjuvant Chemotherapy for Clinical Stages 2 and 3 Gastric Cancer Patients: Analysis of Timing and Site of RecurrenceMasaya Nakauchi, Elvira Vos, Laura H Tang, et al.Annals of Surgical Oncology|April 8, 2021
Association of Obesity with Worse Operative and Oncologic Outcomes for Patients Undergoing Gastric Cancer ResectionMasaya Nakauchi, Elvira L Vos, Laura H Tang, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 5, 2018
Positron-Emission Tomography Scan-Directed Chemoradiation for Esophageal Squamous Cell Carcinoma: No Benefit for a Change in Chemotherapy in Positron-Emission Tomography NonrespondersMegan Greally, Joanne F Chou, Daniela Molena, et al.Pageof 18